Lamivudina Y Zidovudina

Resumen

Alternativas con registro en Colombia

• Lamivudina Y Abacavir
• Tenofovir Disoproxil Y Emtricitabina
• Abacavir/zidovudina/lamivudina
• Efavirenz. Tenofovir Disoproxil Y Emtricitabina
• Emtricitabina. Tenofovir Disoproxil Y Rilpivirina
• Emtricitabina. Tenofovir Disoproxil. Elvitegravir Y Cobicistat
• Lopinavir Y Ritonavir
• Lamivudina. Tenofovir Disoproxil Y Efavirenz
• Lamidubina. Abacavir Y Dolutegravir
• Darunavir Y Cobicistat
• Emtricitabina Y Tenofovir Alafenamida
• Elvitegravir. Cobicistat. Emticitabina. Tenofovir Alafenamida

Estudios clínicos principales

• Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission
  Fase 3 · 2004 · 1.735 participantes · Eunice Kennedy Shriver National Institute of Child Health an · NCT00099359 · PubMed 21666540 · PubMed 18398973
• Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects
  Fase 3 · 2003 · 517 participantes · Gilead Sciences · NCT00112047 · PubMed 16421366
• Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir
  Fase 3 · 2008 · 724 participantes · Gilead Sciences · NCT00708162 · PubMed 22015077
• BRAAVE 2020: Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of
  Fase 3 · 2018 · 496 participantes · Gilead Sciences · NCT03631732 · PubMed 34397746

Enfermedades relacionadas

• Tuberculosis
• VIH

Fuentes

• Etiqueta FDA (DailyMed): LAMIVUDINE and ZIDOVUDINE
• EMA: Trizivir
• EMA: Combivir